3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
7
Uterine Cervical Neoplasms
5
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Retinoblastoma
1
Radiation Injuries
1
Ovarian Neoplasms
1
Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Genital Neoplasms, Female
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Anal Canal Carcinoma
1
Interventions
Surveys and Questionnaires
22
Blood Specimen Collection
13
niraparib
8
Cytoreduction Surgical Procedures
8
Hyperthermic Intraperitoneal Chemotherapy
7
Interviews as Topic
6
Immunohistochemistry
6
olaparib
5
Psychiatric Rehabilitation
5
Polymerase Chain Reaction
5
Magnetic Resonance Spectroscopy
5
Data Collection
5
Carboplatin
5
Amplified Fragment Length Polymorphism Analysis
5
liposomal doxorubicin
4
Geriatric Assessment
4
Bevacizumab
4
1-dodecylpyridoxal
4
Ultrasonography
3
Trabectedin
3
Therapeutics
3
Poly(ADP-ribose) Polymerase Inhibitors
3
Phlebotomy
3
Observation
3
Neoadjuvant Therapy
3
Microarray Analysis
3
Laparoscopy
3
Gene Expression Profiling
3
Flow Cytometry
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Ovarian Neoplasms
×
Brachytherapy
×
Clear all
NCT05242861
2022-02-16
RetroBT
Zhejiang Cancer Hospital
Recruiting
300 enrolled